ARCHIVES

Aranesp Improved Anemia In MDS In Phase II Trial

This article is from The Cancer Letter archive.

Vol. 28 No. 9 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

ODAC Reviews Post-Marketing Studies for Eight Indications

March 21, 2003

House Republicans Move To Slash NIH Spending As Obama Calls For Renewed Investment in Science

February 18, 2011

In Brief: DeVita On Laetrile Hit List; Hammer Removal As Panel Head Sought By Love Canal Activist

November 6, 1981

Paul Goss, Patricia Ganz Discuss Breast Cancer Prevention Trials.

April 20, 2007

MSKCC hopes to raise $1 billion in five-year campaign.

November 7, 2003

NCAB Accepts Report, Seeks Comment From Researchers, Patient Groups

May 19, 1995